206 results
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
7 Mar 24
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
7:00am
General and administrative expenses
Research and development expenses
Amortization of intangible assets
Litigation settlement
Total operating expenses
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
5 Jan 24
Results of Operations and Financial Condition
5:01pm
funding for research and development of advanced therapeutics Rising incidence of disease – cardiac, cancer, respiratory, diabetes, obesity, Alzheimer’s
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
7 Nov 23
Harvard Bioscience Announces Third Quarter 2023 Financial Results
7:00am
Revenues
Cost of revenues
Gross profit
Operating expenses:
Sales and marketing expenses
General and administrative expenses
Research and development expenses
8-K
EX-99.1
r5ykrz 03
8 Aug 23
Harvard Bioscience Announces Second Quarter 2023 Financial Results
9:05am
8-K
EX-10.1
6qo28
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
8-K
EX-99.1
qqzpwyrc7ow0jk aw4a2
25 Apr 23
Harvard Bioscience Announces First Quarter 2023 Financial Results
8:00am
8-K
EX-99.1
d72rp8
8 Nov 22
Harvard Bioscience Announces Third Quarter 2022 Financial Results
4:02pm
8-K
EX-99.1
pu1knzu2s8o5mt 7jr
4 Aug 22
Harvard Bioscience Announces Second Quarter 2022 Financial Results
7:01am
8-K
EX-99.1
8cdjkx3iy0l9j0t
4 May 22
Harvard Bioscience Announces First Quarter 2022 Financial Results
7:01am
8-K
EX-99.1
oeepq uh0ik0
8 Mar 22
Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
7:00am